EURACTIV PR

An easy way of publishing your relevant EU press releases.

Medicines for Europe

Press Releases of this organisation

TITLEsort descending ORGANISATION DATE TOPIC
A new medicines trade and health security agenda for the European Commission Medicines for Europe 19 Feb 2021 Health & Consumers
2017 Biosimilar Medicines Policy Overview: better access is crucial; tailored solutions essential for EU governments Medicines for Europe 12 Sep 2017 Health & Consumers
2018 – A year of unprecedented challenges and opportunities for pharmaceutical regulatory systems Medicines for Europe 25 Jan 2018 Health & Consumers
2022 Health at a Glance Report highlights the need to rethink investments in health after the COVID-19 pandemic Medicines for Europe 05 Dec 2022 Health & Consumers
62% of Medicines Dispensed in Europe are Generic, according to IMS New Data Medicines for Europe 15 Jun 2017 Health & Consumers
A DIGITAL FUTURE FOR VALUE ADDED MEDICINES – IQVIA publication shares the future of the sector Medicines for Europe 24 Sep 2019 Health & Consumers
A step forward for the secure supply of medicines and manufacturing and for public health Medicines for Europe 25 Oct 2023 Health & Consumers
A streamlined, digital regulatory framework is the foundation for equitable access to medicines Medicines for Europe 27 Sep 2023 Health & Consumers
Access to essential medicines threatened by combination of increasing inflation and potential further price cuts in EU countries Medicines for Europe 26 Nov 2021 Health & Consumers
Access to medicines and security of supply should be central to EU pharma and IP legislation reforms in Europe Medicines for Europe 13 Jun 2023 Health & Consumers
Access to medicines critical in European Parliament vote on EU IP action plan Medicines for Europe 12 Nov 2021 Health & Consumers
Access, sustainability and manufacturing competitiveness highlighted at global generic, biosimilar and value added pharmaceutical conference in Budapest Medicines for Europe 14 Jun 2018 Health & Consumers
Addressing medicine shortages in Europe: Competition is crucial for patient access Medicines for Europe 29 Sep 2017 Health & Consumers, Competition
Adjustments to IP framework needed to improve access to medicines in Europe Medicines for Europe 16 Nov 2021 Science & Policymaking
AESGP, EFPIA and Medicines for Europe reflections on the European Medicines Agency, the Heads of Medicines Agencies and the European Commission “Key principles for the use of electronic product information for EU medicines” Medicines for Europe 03 Feb 2021 Health & Consumers
Baton passes from Christoph Stoller to Rebecca Guntern as President of Medicines for Europe Medicines for Europe 01 Oct 2021 Health & Consumers
Billions more euros to re-invest in better healthcare thanks to biosimilar medicines Medicines for Europe 14 Dec 2022 Health & Consumers
Biosimilar medicines have delivered 18BN€ total savings for Europe but more action needed to translate this potential into patient access and sustainable health systems Medicines for Europe 16 Dec 2021 Health & Consumers
Biosimilar Medicines Opportunity: Dramatic Increase in Patient Access across Europe Medicines for Europe 09 May 2017 Health & Consumers
Biosimilar medicines: competition, sustainability and early* access on the agenda of DG GROW stakeholder workshop Medicines for Europe 30 Oct 2019 Health & Consumers
Biosimilar Medicines: essential for sustainable access to medicines Medicines for Europe 27 Apr 2018 Health & Consumers
Brexit - Life Science Industry Joint Position Paper Medicines for Europe 14 Dec 2017 Health & Consumers, UK in Europe
Central & Eastern European patients have inequitable access to medicines for life-threatening conditions Medicines for Europe 25 Apr 2022 Health & Consumers
CJEU decision on Gilead’s SPC on Truvada® leads to successful clarification in English court Medicines for Europe 20 Sep 2018 Health & Consumers
Commission sponsored study shows Supplementary Protection Certificate (SPC) Manufacturing Waiver will create Jobs, strengthen the pharmaceutical sector and reduce medicine costs Medicines for Europe 18 Oct 2017 Health & Consumers
Commission study highlights market framework conditions are main driver for medicines shortages Medicines for Europe 10 Dec 2021 Health & Consumers
Competition policy essential for access to medicines Medicines for Europe 29 Jan 2019 Health & Consumers
Comprehensive SPC manufacturing waiver key for patient access to medicines, jobs and growth in Europe Medicines for Europe 28 May 2018 Health & Consumers, Social Europe & Jobs
Court decision on Supplementary Protection Certificate (SPC) manufacturing waiver risks undermining its use Medicines for Europe 18 Jan 2024 InfoSociety
COVID-19 a lightning rod for major overhaul of EU pharmaceutical policy Medicines for Europe 09 Jul 2020 Health & Consumers

Pages